On May 16, 2024, The Drug Enforcement Administration, Department of Justice published a proposal to transfer marijuana from Schedule I to Schedule III of the
Despite the six months that have passed since the Department of Health and Human Services (HHS) recommendation to the Drug Enforcement Agency (DEA) to reclassify
With four states adding or updating marijuana legislation in 2023, only 10 states remain as outliers, allowing no legal medical or adult-use marijuana. Coming on
As you likely have seen by now, a federal recommendation has been made to reclassify marijuana as a Schedule III drug from its current status
The lack of clear cannabis regulation/acceptance at the federal level has again reared its ugly head causing further complications for both consumers and dispensaries –
State investigators have uncovered numerous instances of marijuana product adulteration by businesses attempting to manipulate contaminant testing. (Colorado MED) One of the fundamental incentives for
We often write about the recall and regulatory implications of quality and safety when producing and retailing cannabis products, but there also are significant implications
Despite the legalization of cannabis in the majority of states across the U.S., the black market continues to thrive in many areas. Why is it
Don’t hold your breath, as we all know how fast the government moves, but there appears to be some additional movement toward the federal descheduling
Regulations legalizing cannabis continue to be proposed at the federal level – with the operative word being proposed. Within the last couple months, a number
